3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
2
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
16
Observational
2
Sponsor
Cancer Type
Myeloid
2
Conditions
Primary Myelofibrosis
1
Polycythemia Vera
1
Bone Marrow Neoplasms
1
Interventions
Blood Specimen Collection
135
Surveys and Questionnaires
132
Specimen Handling
57
Observation
55
Radiotherapy
43
Interviews as Topic
35
Surgical Procedures, Operative
31
Biopsy
30
Drug Therapy
30
Data Collection
25
Magnetic Resonance Spectroscopy
25
Nivolumab
21
Immune Checkpoint Inhibitors
18
Watchful Waiting
18
Standard of Care
17
Therapeutics
17
Immunotherapy
16
Magnetic Resonance Imaging
16
trastuzumab deruxtecan
14
Liquid Biopsy
13
Restraint, Physical
13
Tomography, X-Ray Computed
13
palbociclib
13
Radiosurgery
12
enzalutamide
12
Focus Groups
11
Hematologic Tests
11
apalutamide
11
darolutamide
11
pembrolizumab
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Observational
×
Hydroxyurea
×
1 year
×
Clear all
NCT04217356
2026-01-26
ALLO-BAT
University Health Network, Toronto
Active not recruiting
90 enrolled
NCT05548062
2025-09-03
Prospero
Novartis
Active not recruiting
242 enrolled